Literature DB >> 10767627

The response of Parp knockout mice against DNA damaging agents.

M Masutani1, T Nozaki, K Nakamoto, H Nakagama, H Suzuki, O Kusuoka, M Tsutsumi, T Sugimura.   

Abstract

Gene-disruption studies involving poly(ADP-ribose) polymerase (Parp) have identified the various roles of Parp in cellular responses to DNA damage. The partial rescue of V[D]J recombination process in SCID/Parp(-/-) double mutant mice indicates the participation of Parp in the repair of DNA strand break. Parp(-/-) mice are more sensitive to the lethal effects of alkylating agents. Parp is also thought to be involved in base-excision repair after DNA damage caused by alkylating agents. On the other hand, resistance of Parp(-/-) mice to DNA damage induced by reactive oxygen species implicates the contribution of Parp to cell death through NAD depletion. Parp(-/-) mice with two different genetic backgrounds also show enhanced sensitivity to the lethal effects of gamma-irradiation. Parp(-/-) mice show more severe villous atrophy of the small intestine compared to the wild-type counterpart in a genetic background of 129Sv/C57BL6. Other forms of enhanced tissue damage have been identified in Parp(-/-) mice with a genetic background of 129Sv/ICR. For example, Parp(-/-) mice exhibit extensive hemorrhage in the glandular stomach and other tissues, such as the testes, after gamma-irradiation. Severe myelosuppression is also observed in both Parp(+/+) and Parp(-/-) mice, but Parp(+/+) mice show extensive extramedullary hematopoiesis in the spleen during the recovery phase of post-irradiation, whereas the spleen of Parp(-/-) mice exhibits severe atrophy with no extramedullary hematopoiesis. The absence of extramedullary hematopoiesis in the spleen is probably the underlying mechanism of hemorrhagic tendency in various tissues of Parp(-/-) mice. These findings suggest that loss of Parp activity could contribute to post-irradiation tissue hemorrhage.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10767627     DOI: 10.1016/s1383-5742(00)00033-8

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  33 in total

Review 1.  Potential therapeutic implications of cancer stem cells in glioblastoma.

Authors:  Lin Cheng; Shideng Bao; Jeremy N Rich
Journal:  Biochem Pharmacol       Date:  2010-05-10       Impact factor: 5.858

2.  Loss of poly(ADP-ribose) polymerase-1 causes increased tumour latency in p53-deficient mice.

Authors:  C Conde; M Mark; F J Oliver; A Huber; G de Murcia; J Ménissier-de Murcia
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

3.  Targeting DNA repair with combination veliparib (ABT-888) and temozolomide in patients with metastatic castration-resistant prostate cancer.

Authors:  Maha Hussain; Michael A Carducci; Susan Slovin; Jeremy Cetnar; Jiang Qian; Evelyn M McKeegan; Marion Refici-Buhr; Brenda Chyla; Stacie P Shepherd; Vincent L Giranda; Joshi J Alumkal
Journal:  Invest New Drugs       Date:  2014-04-26       Impact factor: 3.850

Review 4.  Coordination of DNA single strand break repair.

Authors:  Rachel Abbotts; David M Wilson
Journal:  Free Radic Biol Med       Date:  2016-11-24       Impact factor: 7.376

Review 5.  The capacity of oocytes for DNA repair.

Authors:  Jessica M Stringer; Amy Winship; Seng H Liew; Karla Hutt
Journal:  Cell Mol Life Sci       Date:  2018-05-10       Impact factor: 9.261

Review 6.  Exploiting cellular pathways to develop new treatment strategies for AML.

Authors:  Amir T Fathi; Steven Grant; Judith E Karp
Journal:  Cancer Treat Rev       Date:  2010-01-06       Impact factor: 12.111

7.  Role of nicotinamide in DNA damage, mutagenesis, and DNA repair.

Authors:  Devita Surjana; Gary M Halliday; Diona L Damian
Journal:  J Nucleic Acids       Date:  2010-07-25

8.  Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse.

Authors:  Josiane Ménissier de Murcia; Michelle Ricoul; Laurence Tartier; Claude Niedergang; Aline Huber; Françoise Dantzer; Valérie Schreiber; Jean-Christophe Amé; Andrée Dierich; Marianne LeMeur; Laure Sabatier; Pierre Chambon; Gilbert de Murcia
Journal:  EMBO J       Date:  2003-05-01       Impact factor: 11.598

Review 9.  Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

Authors:  Nicola J Curtin; Csaba Szabo
Journal:  Mol Aspects Med       Date:  2013-01-29

10.  Altered hematopoiesis in mice lacking DNA polymerase mu is due to inefficient double-strand break repair.

Authors:  Daniel Lucas; Beatriz Escudero; José Manuel Ligos; Jose Carlos Segovia; Juan Camilo Estrada; Gloria Terrados; Luis Blanco; Enrique Samper; Antonio Bernad
Journal:  PLoS Genet       Date:  2009-02-20       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.